Headache experts have aligned on the best way to prevent migraine attacks. In newly updated guidance, the American Headache Society’s new position statement highlights CGRP inhibitors as the first-line approach to migraine prevention. First approved by the FDA in 2018, the medications can also reduce pain if they’re administered during a migraine attack.
A New First Line of Defense for Migraine
